Buforin II vs Defensin — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Buforin II is a 21-residue antimicrobial peptide derived from histone H2A in the stomach of the Asian toad Bufo gargarizans. Unlike most AMPs that kill bacteria by membrane disruption, Buforin II translocates across bacterial membranes without causing lysis and kills by binding n...
Calculate Buforin II dose →Defensins are a superfamily of small, cysteine-rich cationic antimicrobial peptides that form a critical component of innate immunity across virtually all multicellular organisms. In humans, alpha-defensins (HNP-1 to -4 in neutrophils; HD-5, HD-6 in intestinal Paneth cells) and b...
Calculate Defensin dose →| Parameter | Buforin II | Defensin |
|---|---|---|
| Category | Antimicrobial Peptide | Antimicrobial Peptide |
| Research | Preclinical | Research/Therapeutic Development |
| Half-Life | Minutes (proteolytic) | Minutes-hours (tissue dependent) |
| Typical Dose | N/A | Research only |
| Frequency | N/A | N/A |
| Route | Research only | Endogenous; topical/intranasal (research) |
| FDA Status | Not approved | No approval (research stage) |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.